The Department of Health and Human Services Office for Civil Rights and the Centers for Medicare & Medicaid Services issued a final rule under Section 1557 of the Affordable Care Act (ACA) advancing protections against discrimination in health care. This long-awaited regulation restores the full scope of ACA’s section 1557 non-discrimination protections on the basis of sex, gender identity, or pregnancy status, after the scope of the protections had been limited by the previous administration.
ASCO in Action provides the latest news and analysis related to critical policy issues affecting the cancer community, updates on the Association for Clinical Oncology’s ongoing advocacy efforts, and opportunities for members and others in the cancer care community to take action.
To sign up for advocacy alerts, log in to ASCO.org with your member or guest account, and visit the subscription center available under your account profile.
May 7, 2024
May 7, 2024
The Centers for Medicare & Medicaid Services issued a series of final rules aimed at standardizing several aspects of the Medicaid program. Additionally, the Department of Health and Human Services Health Resources and Services Administration issued the long-awaited 340B Administrative Dispute Resolution final rule. Key points from the four rules are listed.
February 13, 2024
The Centers for Medicare & Medicaid Services (CMS) has finalized prior authorization policy updates within Medicare Advantage (MA), Medicaid Managed Care and Fee for Service, Children’s Health Insurance Plans (CHIP) Managed Care and Fee for Service, and Qualified Health Plans (QHPs) on the Federally Facilitated Exchanges (FFEs). These changes come in response to the Association for Clinical Oncology (ASCO) and other stakeholder concerns that prior authorization processes limit beneficiary access to care in Medicare Advantage.